Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

PubMed

Regulatory Approved Point-of-Care Diagnostics (FDA & Health Canada): A Comprehensive Framework for Analytical Validity, Clinical Validity, and Clinical Utility in Medical Devices.

PMID: 40794850 · 2025

JournalThe journal of applied laboratory medicine
Year2025
PMID40794850

Abstract

Point-of-care (POC) diagnostic devices deliver rapid, near-patient results that drive timely clinical decisions across diverse settings (from emergency departments to home care). Their decentralized deployment mandates a rigorous, multi-phase validation strategy to ensure analytical accuracy, clinical reliability, and real-world utility before both regulatory clearance and reimbursement. We propose an expanded, integrated framework comprising 4 pillars:Analytical validity: Quantification of sens

Official Source

View on PubMed →

Data sourced from PubMed / NCBI. For the full text and most current information, always refer to the official record.